Public Health
ICCVAM Home >> Test Method Evaluations >> Immunotoxicity >> Electrophilic Allergen Screening Assay

Evaluation of Integrated Testing Strategies to Identify Potential Sensitizers

Site Map
Site Map

NICEATM is evaluating the integration of data from various sources into testing strategies that can be used to reduce animal use to identify substances with the potential to cause allergic contact dermatitis (ACD). One approach involves combining an assessment of physical and chemical properties and data from an in vitro test method with use of the murine local lymph node assay (LLNA). This approach has the potential to reduce animal use by 67% compared with use of the LLNA alone.

Background and Details on the Test Methods

Skin sensitizers are substances with the potential to cause ACD, and skin sensitization is the process by which a sensitizer induces the development of ACD. The biochemical pathway leading to skin sensitization includes several steps: penetration of the potential sensitizer into the skin, binding to proteins in the skin, mobilization of immune cells in response to the sensitizer, proliferation of cells in the lymph nodes stimulated by immune cell activity, and skin inflammation upon subsequent exposure to the potential sensitizer.

The potential for a substance to bind with skin proteins can be assessed by evaluating its physical and chemical properties and by testing the substance using the electrophilic allergen screening assay (EASA). The EASA identifies a potential sensitizer by measuring binding of a test substance to chemical probes that contain structures commonly found in skin proteins. The developer of the EASA submitted a nomination in 2012 requesting that NICEATM and ICCVAM evaluate this method as a screening assay for identification of potential sensitizers.

The LLNA measures the proliferation of lymph node cells after application of a substance to the skin of a test animal, and has been recommended by ICCVAM to identify potential sensitizers. While updated versions of the LLNA enable substantial reductions in animal use, use of the LLNA in combination with the EASA and evaluation of a substance’s physical and chemical structure may enable the identification of potential sensitizers using even fewer animals.

View other relevant documents


  Back to Top

File Assistance: Free downloads for viewing files.

USA.gov is the U.S. government's official web
portal to all federal, state, and local government web resources and services U.S. Department of Health and Human Services
The NTP is located at the National Institute of Environmental Health Sciences, part of the National Institutes of Health.